# Cumberland Pharmaceuticals Inc: Form 8-K, filed May 3, 2022

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2022-05-03
- Accepted by EDGAR: May 3, 2022, 17:11 ET
- Period: 2022-05-03
- Accession: 0001628280-22-012039
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828022012039/cpix-20220503.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828022012039/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828022012039/cpix-20220503.htm

Filed May 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-012039. Last ingested by Listed: Nov 14, 2026, 23:39 ET. No prices; not investment advice.
